ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
11.57
+0.47 (4.23%)
May 6, 2026, 1:34 PM EDT - Market open
ClearPoint Neuro Revenue
In the year 2025, ClearPoint Neuro had annual revenue of $36.97M with 17.78% growth. ClearPoint Neuro had revenue of $10.41M in the quarter ending December 31, 2025, with 33.96% growth.
Revenue (ttm)
$36.97M
Revenue Growth
+17.78%
P/S Ratio
9.07
Revenue / Employee
$214,948
Employees
172
Market Cap
346.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.97M | 5.58M | 17.78% |
| Dec 31, 2024 | 31.39M | 7.44M | 31.04% |
| Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
| Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
| Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
| Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
| Dec 31, 2019 | 11.22M | 3.86M | 52.54% |
| Dec 31, 2018 | 7.35M | -26.26K | -0.36% |
| Dec 31, 2017 | 7.38M | 1.63M | 28.35% |
| Dec 31, 2016 | 5.75M | 1.16M | 25.15% |
| Dec 31, 2015 | 4.59M | 989.71K | 27.46% |
| Dec 31, 2014 | 3.60M | -326.10K | -8.30% |
| Dec 31, 2013 | 3.93M | -1.13M | -22.29% |
| Dec 31, 2012 | 5.06M | 1.24M | 32.48% |
| Dec 31, 2011 | 3.82M | 1.15M | 43.03% |
| Dec 31, 2010 | 2.67M | 69.45K | 2.67% |
| Dec 31, 2009 | 2.60M | 650.00K | 33.33% |
| Dec 31, 2008 | 1.95M | 1.83M | 1,460.00% |
| Dec 31, 2007 | 125.00K | -842.83K | -87.08% |
| Dec 31, 2006 | 967.83K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viemed Healthcare | 270.28M |
| OrthoPediatrics | 243.30M |
| RxSight | 134.48M |
| Beta Bionics | 110.24M |
| Standard BioTools | 85.33M |
| Delcath Systems | 85.23M |
| 908 Devices | 56.20M |
| TriSalus Life Sciences | 45.15M |
CLPT News
- 6 days ago - ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026 - Accesswire
- 13 days ago - ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Accesswire
- 15 days ago - ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Accesswire
- 7 weeks ago - ClearPoint Neuro Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results - Accesswire
- 2 months ago - ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 - Accesswire
- 3 months ago - ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software - Benzinga
- 3 months ago - ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - Accesswire